FY2025 · period end Dec '25 · from the 10-K filed Apr 8, 2026
Data as filed with the SEC, provided for information only — not investment advice.
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | $0.07B | $0.00B | negative: -$0.02B | negative: -$0.38B | negative: -$0.14B |
| Net Income | $0.05B | negative: -$0.01B | negative: -$0.16B | negative: -$0.36B | negative: -$0.82B |
| EPS (Diluted) | $2.07 | negative: -$0.01 | negative: -$0.14 | negative: -$2.20 | negative: -$13.76 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $0.85B | $0.70B | $5.49B | $5.05B | $1.18B |
| Total Liabilities | $1.98B | $1.40B | $1.78B | $1.17B | $0.17B |
| Stockholders' Equity | $3.99B | $0.51B | $0.52B | $3.88B | $1.01B |
| Cash & Equivalents | $0.22B | $0.27B | $1.98B | $1.70B | $1.36B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | negative: -$0.06B | $0.09B | $0.03B | $0.13B | negative: -$0.16B |
| Capital Expenditures | $0.14B | $0.01B | $0.09B | $0.06B | $0.01B |
| Free Cash Flow | negative: -$0.20B | $0.08B | negative: -$0.05B | $0.07B | negative: -$0.17B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — |
| Operating Margin | — | — | — | — | — |
| Net Margin | — | — | — | — | — |
| Return on Equity | 8.8% | negative: -0.2% | negative: -4.1% | negative: -47.9% | negative: -12.7% |
| Return on Assets | 6.1% | negative: -0.2% | negative: -3.0% | negative: -39.3% | negative: -12.8% |
| Debt / Equity | 0.08× | 0.06× | 0.09× | 0.03× | 0.01× |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or full history back to 1993 plus the smart-money dataset and webhooks on Institutional.
Who is buying and selling ATRenew Inc. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on RERE yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on RERE and publish the result to your public profile.
Ask about ATRenew Inc.
Continue in Workspace — cited answers on RERE, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate, with delisted companies kept in.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 20-F | 0001193125-26-146260 | Dec 31, 2025 | Apr 8, 2026 | Apr 8, 2026 10:05 UTC | EDGAR |
| 20-F | 0000950170-25-053014 | Dec 31, 2024 | Apr 11, 2025 | Apr 11, 2025 10:06 UTC | EDGAR |
| 20-F | 0000950170-24-043854 | Dec 31, 2023 | Apr 12, 2024 | Apr 12, 2024 10:07 UTC | EDGAR |
| 20-F | 0000950170-23-013162 | Dec 31, 2022 | Apr 18, 2023 | Apr 18, 2023 11:03 UTC | EDGAR |
| 20-F | 0001564590-22-016124 | Dec 31, 2021 | Apr 27, 2022 | Apr 27, 2022 20:55 UTC | EDGAR |
Direct links to SEC EDGAR. RERE has additional filings available on the SEC site.
6 numbers ATRenew Inc. later changed — same XBRL tag, both filings linked.
Depreciation·FY 2023
Major restatementwas43.1MCNY
Revised up in a 20-F.
Other Liabilities, Current·As of Dec 31, 2021
Major restatementwas93.5MCNY
Revised down in a 20-F.
Other Liabilities, Current·As of Dec 31, 2023
Major restatementwas31.5MCNY
Revised down in a 20-F.
Accounts Receivable, Allowance for Credit Loss·As of Dec 31, 2024
Major restatementwas17.8MCNY
Revised down in a 20-F.
Prepaid Expense and Other Assets, Current·As of Dec 31, 2024
Notable restatementwas598MCNY
Revised down in a 20-F.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations·As of Dec 31, 2021
Notable restatementwas$236.4M
Revised down in a 20-F.
RERE is not the only one.
See every restatement we've found across the market — or get an alert the next time RERE revises a number.
Restatements are detected by comparing every vintage of a fact across all of ATRenew Inc.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows RERE's most significant revisions, and a figure absent from it has not been certified as unrevised.
